In contrast to the EGF-targeted toxins, the EGFR inhibitor erlotinib showed no measurable cytotoxicity in the PCa cells up to a concentration of 5750 nM after 72 h (Table 1, Figure S2). This evidence concerns the gene EGF and posterior cortical atrophy.